Authors
Carlo Lazzaro, Giovanna Esposito, Anna Cantarutti, Francesco Parazzini, Giovanni Corrao, Matteo Franchi, Fabio Parazzini
Published in
Expert review of pharmacoeconomics & outcomes research. Aug 12, 2026. Epub Aug 12, 2026.
Abstract
gestational hypertension (GH) is a common complication that affects approximately 5% of pregnancies worldwide.
presenting a model-based cost description of managing severe GH in inward setting following the Italian National Health Service (INHS) perspective. Epidemiological data on pregnancies and severe GH were obtained from Lombardy region and extrapolated to national level for 2024 (last available year). Health care resources for managing severe GH patients aged 20-49 years with severe GH, identified and quantified according to literature and expert' opinion, were valued through INHS tariffs (2025 values). One-way and scenario sensitivity analyses tested the robustness of the baseline findings.
375,553 pregnancies and 1928 episodes of severe GH needing hospitalization (0.51% of all pregnancies) were estimated for Italy in 2024. The overall average cost of managing a severe GH episode reaches €752.64. Inward hospitalization (€454.23) is the main cost-driver (60.04% of the total), as confirmed by one-way and scenario sensitivity analyses.
as reported in research conducted in other countries, inward hospitalization is both essential and the main cost-driver for the optimal management of severe GH. Outpatient programmes aimed at identifying and following-up GH patients before the disease requires hospitalization should be considered by INHS policymakers.
PMID:
42583945
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0